Embolic protection during saphenous vein graft interventions

Journal of Invasive Cardiology

Volumn 21, Issue 8, 2009, Pages 415-417

  Banerjee, Subhash ^a   Brilakis, Emmanouil S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL EMBOLISM; BALLOON; CLINICAL TRIAL; DEVICE; EMBOLIC PROTECTION DEVICE; HEART INFARCTION; HUMAN; REVIEW; RISK ASSESSMENT; SAPHENOUS VEIN GRAFT; STENT;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; EMBOLISM; GRAFT OCCLUSION, VASCULAR; HUMANS; MYOCARDIAL INFARCTION; REGIONAL BLOOD FLOW; RISK FACTORS; SAPHENOUS VEIN;

EID: 69249137964     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Lee CH, Wong HB, Tan HC, et al. Impact of reversibility of no reflow phenomenon on 30-day mortality following percutaneous revascularization for acute myocardial infarction-insights from a 1,328 patient registry. J Interv Cardiol 2005;18:261-266.
2. Baim DS, Wahr D, George B, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002;105:1285-1290. (Pubitemid 34260417)
3. Michaels AD, Appleby M, Otten MH, et al. Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: Results of the randomized, controlled vasodilator prevention on no-reflow (VAPOR) trial. J Invasive Cardiol 2002;14:299-302. (Pubitemid 34651235)
4. Zoghbi GJ, Goyal M, Hage F, et al. Pretreatment with nitroprusside for microcirculatory protection in saphenous vein graft interventions. J Invasive Cardiol 2009;21:34-39.
5. Sdringola S, Assali A, Ghani M, et al. Adenosine use during aortocoronary vein graft interventions reverses but does not prevent the slow-no reflow phenomenon. Catheter Cardiovasc Interv 2000;51:394-399.
6. Gibson CM, Cannon CP, Murphy SA, et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 2000;101:125-130.
7. Roffi M, Mukherjee D, Chew DP, et al. Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: A pooled analysis of five randomized clinical trials. Circulation 2002;106:3063-3067. (Pubitemid 35440289)
8. Leborgne L, Cheneau E, Pichard A, et al. Effect of direct stenting on clinical outcome in patients treated with percutaneous coronary intervention on saphenous vein graft. Am Heart J 2003;146:501-506. (Pubitemid 37083086)
9. Iakovou I, Dangas G, Mintz GS, et al. Relation of final lumen dimensions in saphenous vein grafts after stent implantation to outcome. Am J Cardiol 2004;93:963-968. (Pubitemid 38479447)
10. Stankovic G, Colombo A, Presbitero P, et al. Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: The Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial. Circulation 2003;108:37-42. (Pubitemid 36859017)
11. Lim MJ, Young JJ, Senter SR, Klein LW. Determinants of embolic protection device use: case study in the acceptance of a new medical technology. Catheter Cardiovasc Interv 2005;65:597-599.
12. Coolong A, Baim DS, Kuntz RE, et al. Saphenous vein graft stenting and major adverse cardiac events: A predictive model derived from a pooled analysis of 3958 patients. Circulation 2008;117:790-797. (Pubitemid 351640680)
13. Mehta SK, Frutkin AD, Milford-Beland S, et al. Utilization of distal embolic protection in saphenous vein graft interventions (an analysis of 19,546 patients in the American College of Cardiology-National Cardiovascular Data Registry). Am J Cardiol 2007;100:1114-1118. (Pubitemid 47404467)
14. Mauri L, Cox D, Hermiller J, et al. The PROXIMAL trial: Proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: A randomized, prospective, multicenter clinical trial. J Am Coll Cardiol 2007;50:1442-1449. (Pubitemid 47494591)
15. Grow P, Rab ST. Percutaneous saphenous vein graft intervention with sequential embolic protection devices: Complementing lesion anatomy with embolic protection device. Catheter Cardiovasc Interv 2008;72:636-640.
16. Brilakis ES, Banerjee S. The "Proxis-Tornus" technique for a difficult-to-cross calcified saphenous vein graft lesion. J Invasive Cardiol 2008;20:E258-E261.